Keybanc analyst Sophie Karp maintains Sunrun (NASDAQ:RUN) with a Overweight and lowers the price target from $74 to $70.
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.
